The most up-to-date information for company-wide success.

Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet report easily usable by your marketing, business development, product management teams, and company executives.

With this data on hand your company will always have the most up-to-date information on the size and growth of the molecular diagnostics market. Also included in each update is how fluctuations in major global currencies have affected real growth for each of the markets examined. Corporate leadership teams can use the Datastream as a guide to help determine quarterly market share, and to measure your company’s growth against the industry as a whole.

Quarterly Market estimates include:

• Molecular Infectious Disease (Respiratory, Hepatitis, HIV, HAIs/Sepsis, STI, TB and Other Infections)
• Molecular Oncology (Molecular Assays including CDx and Molecular Histology)
• Molecular Genetic Testing (Inherited Diseases and NIPT)
• Molecular Transplantation
• Molecular NAT Blood Banking Tests
• Molecular Molecular Point of Care Tests
• Molecular COVID Testing